Abstract
Merkel cell carcinoma (MMC) is a rare primary neuroendocrine skin tumor associated with a poor prognosis. MMC is histologically similar to small cell lung carcinoma. The incidence of MCC is increasing with a median age of discovery of approximately 70 years old. Treatment of MCC, which usually occurs in sun-exposed skin, includes surgery with reconstruction associated with radiotherapy and/or chemotherapy for advanced stages including widespread metastases. We report two cases of Merkel cell carcinoma in 76 and 84 year old patients and describe the natural history of this cancer and management in geriatric patients. Merkel cell carcinoma (MCC) is a rare cancer with high malignant potential that mainly affects people over the age of 65. It must be diagnosed early to improve the prognosis. The survival rate at 5 years for local or regional invasion is 65%. The median survival for metastasized stages is 10 months. The therapeutic regimen recommended for the treatment of MCC is influenced by the geriatric status of patients, and a multidisciplinary oncogeriatric approach could be of interest.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Grim M, Halata Z. Developmental origin of avian Merkel cells. Anat Embryol (Berl). 2000 Nov;202(5):401–410.
Ott MJ, Tanabe KK, Gadd MA, Stark P, Smith BL, Finkelstein DM, et al. Multimodality management of Merkel cell carcinoma. Arch Surg. 1999 Apr; 134(4): 388–392; discussion 92–3.
Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2): 153–158.
Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. Merkel cell carcinoma and HTV infection. Lancet. 2002 Feb 9;359(9305):497–498.
Penn I, First MR. Merkel’s cell carcinoma in organ recipients: report of 41 cases. Transplantation. 1999 Dec 15;68(11): 1717–1721.
Group RMCC. Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol. 2009 Aug 20;27(24):4021–4026.
Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008 Feb 22;319(5866): 1096–1100.
Bichakjian CK, Lowe L, Lao CD, Sandler HM, Bradford CR, Johnson TM, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer. 2007 Jul 1;110(1):1–12.
Hitchcock CL, Bland KI, Laney RG. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg. 1988 Feb;207(2):201–207.
Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007 May 10;25(14): 1824–1831.
Balducci L. The geriatric cancer patient: equal benefit from equal treatment. Cancer Control. 2001 Mar–Apr;8(2 Suppl):1–25; quiz 7–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miranda, S., Gbaguidi, X., Carvalho, P. et al. Merckel cell carcinoma: The impact of multidisciplinary management. J Nutr Health Aging 17, 196–198 (2013). https://doi.org/10.1007/s12603-012-0375-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-012-0375-7